UTHR - Why Is Pulmonary Hypertension-Focused Liquidia Stock Soaring Today? | Benzinga
Liquidia Corp (NASDAQ: LQDA) stock jumped after a win in a patent dispute with United Therapeutics Corporation (NASDAQ: UTHR) revolving around U.S. Patent 10,716,793 (the ’793 patent).
"We have considered United Therapeutics (UTC's) remaining arguments and find them unpersuasive," the three judge panel wrote in its decision. "For the reasons provided above, we affirm the Board's unpatentability determination."
United Therapeutics owns the ’793 patent, which is directed ...